Imanova imaging scientists can provide strategic input into drug discovery and development plans to optimise the best use of imaging studies. We can integrate these novel imaging applications into existing studies and development plans. This can contribute to a seamless transition from preclinical to clinical development and give confidence in answering key early development questions.
The capabilities and experience within our organisation allows us to apply established analysis methodologies or develop customised solutions to meet individual requirements of our customers. We have significant experience in helping our customers with:
- Study design to answer key questions in early drug development
- Analysis and interpretation of PET/MRI/CT studies, even if the scanning is done elsewhere
- Maintenance of analysis audit trails
By developing flexible and smart study protocols we are able to utilise complex PET and MRI methodologies to their best advantage. Our focus is always to use intelligent study designs that capture the required data and apply the appropriate bio-mathematical models that deliver quantitative endpoints to allow data-driven decision making for our customers.